1	Suppression	_	NN	_	_	0	ROOT	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	GATA-3	_	NN	_	_	5	NMOD	_	_
4	Nuclear	_	JJ	_	_	5	NMOD	_	_
5	Import	_	NN	_	_	2	PMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	Phosphorylation	_	NN	_	_	6	CONJ	_	_
8	:	_	:	_	_	1	P	_	_
9	A	_	DT	_	_	11	NMOD	_	_
10	Novel	_	JJ	_	_	11	NMOD	_	_
11	Mechanism	_	NN	_	_	1	APPO	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	Corticosteroid	_	NN	_	_	14	NMOD	_	_
14	Action	_	NN	_	_	12	PMOD	_	_
15	in	_	IN	_	_	11	NMOD	_	_
16	Allergic	_	JJ	_	_	17	NMOD	_	_
17	Disease	_	NN	_	_	15	PMOD	_	_
		
1	Background	_	NN	_	_	0	ROOT	_	_
		
1	GATA-3	_	NN	_	_	2	VMOD	_	_
2	plays	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	5	NMOD	_	_
4	critical	_	JJ	_	_	5	NMOD	_	_
5	role	_	NN	_	_	2	VMOD	_	_
6	in	_	IN	_	_	2	VMOD	_	_
7	regulating	_	VBG	_	_	6	PMOD	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	7	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	cytokines	_	NNS	_	_	10	PMOD	_	_
13	interleukin	_	NN	_	_	15	NMOD	_	_
14	(	_	(	_	_	15	P	_	_
15	IL	_	NN	_	_	12	APPO	_	_
16	)	_	)	_	_	15	P	_	_
17	-4	_	CD	_	_	15	NMOD	_	_
18	,	_	,	_	_	15	P	_	_
19	IL-5	_	NN	_	_	15	COORD	_	_
20	,	_	,	_	_	19	P	_	_
21	and	_	CC	_	_	19	COORD	_	_
22	IL-13	_	NN	_	_	21	CONJ	_	_
23	from	_	IN	_	_	12	NMOD	_	_
24	T	_	NN	_	_	29	NMOD	_	_
25	helper-2	_	NN	_	_	29	NMOD	_	_
26	(	_	(	_	_	29	P	_	_
27	Th2	_	NN	_	_	29	NMOD	_	_
28	)	_	)	_	_	29	P	_	_
29	cells	_	NNS	_	_	23	PMOD	_	_
30	and	_	CC	_	_	2	COORD	_	_
31	therefore	_	RB	_	_	2	VMOD	_	_
32	is	_	VBZ	_	_	30	CONJ	_	_
33	a	_	DT	_	_	35	NMOD	_	_
34	key	_	JJ	_	_	35	NMOD	_	_
35	mediator	_	NN	_	_	32	VMOD	_	_
36	of	_	IN	_	_	35	NMOD	_	_
37	allergic	_	JJ	_	_	38	NMOD	_	_
38	diseases	_	NNS	_	_	36	PMOD	_	_
39	.	_	.	_	_	2	P	_	_
		
1	Corticosteroids	_	NNS	_	_	2	VMOD	_	_
2	are	_	VBP	_	_	0	ROOT	_	_
3	highly	_	RB	_	_	4	AMOD	_	_
4	effective	_	JJ	_	_	2	VMOD	_	_
5	in	_	IN	_	_	4	AMOD	_	_
6	suppressing	_	VBG	_	_	5	PMOD	_	_
7	allergic	_	JJ	_	_	8	NMOD	_	_
8	inflammation	_	NN	_	_	6	VMOD	_	_
9	,	_	,	_	_	2	P	_	_
10	but	_	CC	_	_	2	COORD	_	_
11	their	_	PRP$	_	_	12	NMOD	_	_
12	effects	_	NNS	_	_	15	VMOD	_	_
13	on	_	IN	_	_	12	NMOD	_	_
14	GATA-3	_	NN	_	_	13	PMOD	_	_
15	are	_	VBP	_	_	10	CONJ	_	_
16	unknown	_	JJ	_	_	15	VMOD	_	_
17	.	_	.	_	_	2	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	investigated	_	VBD	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	effect	_	NN	_	_	2	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	corticosteroid	_	NN	_	_	9	NMOD	_	_
8	fluticasone	_	NN	_	_	9	NMOD	_	_
9	propionate	_	NN	_	_	5	PMOD	_	_
10	on	_	IN	_	_	4	NMOD	_	_
11	GATA-3	_	NN	_	_	12	NMOD	_	_
12	regulation	_	NN	_	_	10	PMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	human	_	JJ	_	_	15	NMOD	_	_
15	T-lymphocytes	_	NNS	_	_	13	PMOD	_	_
16	in	_	FW	_	_	2	VMOD	_	_
17	vitro	_	FW	_	_	16	AMOD	_	_
18	and	_	CC	_	_	16	COORD	_	_
19	in	_	FW	_	_	18	CONJ	_	_
20	vivo	_	FW	_	_	19	AMOD	_	_
21	.	_	.	_	_	2	P	_	_
		
1	Methods	_	NNS	_	_	0	ROOT	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	Findings	_	NNS	_	_	2	CONJ	_	_
		
1	In	_	IN	_	_	23	VMOD	_	_
2	a	_	DT	_	_	6	NMOD	_	_
3	T	_	NN	_	_	6	NMOD	_	_
4	lymphocyte	_	NN	_	_	6	NMOD	_	_
5	cell	_	NN	_	_	6	NMOD	_	_
6	line	_	NN	_	_	1	PMOD	_	_
7	(	_	(	_	_	8	P	_	_
8	HuT-78	_	NN	_	_	6	PRN	_	_
9	)	_	)	_	_	8	P	_	_
10	and	_	CC	_	_	6	COORD	_	_
11	peripheral	_	JJ	_	_	14	NMOD	_	_
12	blood	_	NN	_	_	14	NMOD	_	_
13	mononuclear	_	JJ	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	10	CONJ	_	_
15	stimulated	_	VBN	_	_	14	APPO	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	anti-CD3	_	NN	_	_	16	PMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	anti-CD28	_	NN	_	_	18	CONJ	_	_
20	in	_	FW	_	_	19	NMOD	_	_
21	vitro	_	FW	_	_	19	NMOD	_	_
22	we	_	PRP	_	_	23	VMOD	_	_
23	demonstrated	_	VBD	_	_	0	ROOT	_	_
24	that	_	IN	_	_	23	VMOD	_	_
25	fluticasone	_	NN	_	_	26	VMOD	_	_
26	inhibits	_	VBZ	_	_	24	SUB	_	_
27	nuclear	_	JJ	_	_	28	NMOD	_	_
28	translocation	_	NN	_	_	26	VMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	GATA-3	_	NN	_	_	29	PMOD	_	_
31	and	_	CC	_	_	28	COORD	_	_
32	expression	_	NN	_	_	31	CONJ	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	Th2	_	NN	_	_	35	NMOD	_	_
35	cytokines	_	NNS	_	_	33	PMOD	_	_
36	via	_	IN	_	_	26	VMOD	_	_
37	a	_	DT	_	_	38	NMOD	_	_
38	mechanism	_	NN	_	_	36	PMOD	_	_
39	independent	_	JJ	_	_	38	APPO	_	_
40	of	_	IN	_	_	39	AMOD	_	_
41	nuclear	_	JJ	_	_	42	NMOD	_	_
42	factor-kappaB	_	NN	_	_	40	PMOD	_	_
43	and	_	CC	_	_	26	COORD	_	_
44	is	_	VBZ	_	_	43	CONJ	_	_
45	due	_	JJ	_	_	44	VMOD	_	_
46	,	_	,	_	_	45	P	_	_
47	in	_	IN	_	_	45	AMOD	_	_
48	part	_	NN	_	_	47	PMOD	_	_
49	,	_	,	_	_	45	P	_	_
50	to	_	TO	_	_	45	AMOD	_	_
51	competition	_	NN	_	_	50	PMOD	_	_
52	between	_	IN	_	_	51	NMOD	_	_
53	GATA-3	_	NN	_	_	52	PMOD	_	_
54	and	_	CC	_	_	53	COORD	_	_
55	the	_	DT	_	_	58	NMOD	_	_
56	ligand-activated	_	JJ	_	_	58	NMOD	_	_
57	glucocorticoid	_	NN	_	_	58	NMOD	_	_
58	receptor	_	NN	_	_	54	CONJ	_	_
59	for	_	IN	_	_	51	NMOD	_	_
60	nuclear	_	JJ	_	_	61	NMOD	_	_
61	transport	_	NN	_	_	59	PMOD	_	_
62	through	_	IN	_	_	61	NMOD	_	_
63	the	_	DT	_	_	66	NMOD	_	_
64	nuclear	_	JJ	_	_	66	NMOD	_	_
65	importer	_	NN	_	_	66	NMOD	_	_
66	importin-alpha	_	NN	_	_	62	PMOD	_	_
67	.	_	.	_	_	23	P	_	_
		
1	In	_	IN	_	_	5	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	fluticasone	_	NN	_	_	5	VMOD	_	_
5	induces	_	VBZ	_	_	0	ROOT	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	expression	_	NN	_	_	5	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	mitogen-activated	_	JJ	_	_	11	NMOD	_	_
10	protein	_	NN	_	_	11	NMOD	_	_
11	kinase	_	NN	_	_	15	NMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	MAPK	_	NN	_	_	11	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	phosphatase-1	_	NN	_	_	8	PMOD	_	_
16	(	_	(	_	_	17	P	_	_
17	MKP-1	_	NN	_	_	15	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	,	_	,	_	_	15	P	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	endogenous	_	JJ	_	_	22	NMOD	_	_
22	inhibitor	_	NN	_	_	15	APPO	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	p38	_	NN	_	_	25	NMOD	_	_
25	MAPK	_	NN	_	_	23	PMOD	_	_
26	,	_	,	_	_	15	P	_	_
27	which	_	WDT	_	_	28	VMOD	_	_
28	is	_	VBZ	_	_	15	NMOD	_	_
29	necessary	_	JJ	_	_	28	VMOD	_	_
30	for	_	IN	_	_	29	AMOD	_	_
31	GATA-3	_	NN	_	_	33	NMOD	_	_
32	nuclear	_	JJ	_	_	33	NMOD	_	_
33	translocation	_	NN	_	_	30	PMOD	_	_
34	.	_	.	_	_	5	P	_	_
		
1	These	_	DT	_	_	3	NMOD	_	_
2	inhibitory	_	JJ	_	_	3	NMOD	_	_
3	effects	_	NNS	_	_	6	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	fluticasone	_	NN	_	_	4	PMOD	_	_
6	are	_	VBP	_	_	0	ROOT	_	_
7	rapid	_	JJ	_	_	6	VMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	potent	_	JJ	_	_	7	COORD	_	_
10	,	_	,	_	_	9	P	_	_
11	and	_	CC	_	_	9	COORD	_	_
12	prolonged	_	JJ	_	_	11	CONJ	_	_
13	.	_	.	_	_	6	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	also	_	RB	_	_	3	VMOD	_	_
3	demonstrated	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	inhaled	_	JJ	_	_	6	NMOD	_	_
6	fluticasone	_	NN	_	_	7	VMOD	_	_
7	inhibits	_	VBZ	_	_	4	SUB	_	_
8	GATA-3	_	NN	_	_	10	NMOD	_	_
9	nuclear	_	JJ	_	_	10	NMOD	_	_
10	translocation	_	NN	_	_	7	VMOD	_	_
11	in	_	IN	_	_	10	NMOD	_	_
12	peripheral	_	JJ	_	_	14	NMOD	_	_
13	blood	_	NN	_	_	14	NMOD	_	_
14	lymphocytes	_	NNS	_	_	11	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	patients	_	NNS	_	_	15	PMOD	_	_
17	with	_	IN	_	_	16	NMOD	_	_
18	asthma	_	NN	_	_	17	PMOD	_	_
19	in	_	FW	_	_	7	VMOD	_	_
20	vivo	_	FW	_	_	19	AMOD	_	_
21	.	_	.	_	_	3	P	_	_
		
1	Conclusions	_	NNS	_	_	0	ROOT	_	_
		
1	Corticosteroids	_	NNS	_	_	2	VMOD	_	_
2	have	_	VBP	_	_	0	ROOT	_	_
3	a	_	DT	_	_	6	NMOD	_	_
4	potent	_	JJ	_	_	6	NMOD	_	_
5	inhibitory	_	JJ	_	_	6	NMOD	_	_
6	effect	_	NN	_	_	2	VMOD	_	_
7	on	_	IN	_	_	6	NMOD	_	_
8	GATA-3	_	NN	_	_	7	PMOD	_	_
9	via	_	IN	_	_	2	VMOD	_	_
10	two	_	CD	_	_	12	NMOD	_	_
11	interacting	_	VBG	_	_	12	NMOD	_	_
12	mechanisms	_	NNS	_	_	9	PMOD	_	_
13	that	_	WDT	_	_	15	VMOD	_	_
14	potently	_	RB	_	_	15	VMOD	_	_
15	suppress	_	VBP	_	_	12	NMOD	_	_
16	Th2	_	NN	_	_	18	NMOD	_	_
17	cytokine	_	NN	_	_	18	NMOD	_	_
18	expression	_	NN	_	_	15	VMOD	_	_
19	.	_	.	_	_	2	P	_	_
		
1	This	_	DT	_	_	3	NMOD	_	_
2	novel	_	JJ	_	_	3	NMOD	_	_
3	mechanism	_	NN	_	_	8	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	action	_	NN	_	_	4	PMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	corticosteroids	_	NNS	_	_	6	PMOD	_	_
8	may	_	MD	_	_	0	ROOT	_	_
9	account	_	VB	_	_	8	VC	_	_
10	for	_	IN	_	_	9	VMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	striking	_	JJ	_	_	14	NMOD	_	_
13	clinical	_	JJ	_	_	14	NMOD	_	_
14	efficacy	_	NN	_	_	10	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	corticosteroids	_	NNS	_	_	15	PMOD	_	_
17	in	_	IN	_	_	14	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	treatment	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	allergic	_	JJ	_	_	22	NMOD	_	_
22	diseases	_	NNS	_	_	20	PMOD	_	_
23	.	_	.	_	_	8	P	_	_
		
1	Please	_	NN	_	_	2	VMOD	_	_
2	see	_	VB	_	_	0	ROOT	_	_
3	later	_	RB	_	_	2	VMOD	_	_
4	in	_	IN	_	_	2	VMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	article	_	NN	_	_	4	PMOD	_	_
7	for	_	IN	_	_	2	VMOD	_	_
8	Editors	_	NNS	_	_	10	NMOD	_	_
9	'	_	POS	_	_	10	SUFFIX	_	_
10	Summary	_	NN	_	_	7	PMOD	_	_
		
